DK1328538T3 - Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener - Google Patents

Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener

Info

Publication number
DK1328538T3
DK1328538T3 DK01972358T DK01972358T DK1328538T3 DK 1328538 T3 DK1328538 T3 DK 1328538T3 DK 01972358 T DK01972358 T DK 01972358T DK 01972358 T DK01972358 T DK 01972358T DK 1328538 T3 DK1328538 T3 DK 1328538T3
Authority
DK
Denmark
Prior art keywords
antiestrogens
intermediates
substituted
preparation
substituted antiestrogens
Prior art date
Application number
DK01972358T
Other languages
English (en)
Inventor
Robert Stevenson
Fraser Witton Kerr
Anthony Raymond Lane
Eve Joanne Brazier
Philip John Hogan
David Dermot Patrick Laffan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9901292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1328538(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1328538T3 publication Critical patent/DK1328538T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK01972358T 2000-10-14 2001-10-09 Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener DK1328538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025221.3A GB0025221D0 (en) 2000-10-14 2000-10-14 New process
PCT/GB2001/004485 WO2002032922A1 (en) 2000-10-14 2001-10-09 Process and intermediates for the production of 7-substituted antiestrogens

Publications (1)

Publication Number Publication Date
DK1328538T3 true DK1328538T3 (da) 2008-11-03

Family

ID=9901292

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01972358T DK1328538T3 (da) 2000-10-14 2001-10-09 Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener

Country Status (26)

Country Link
US (1) US7947667B2 (da)
EP (2) EP1918295B1 (da)
JP (2) JP4363846B2 (da)
KR (2) KR20080056029A (da)
CN (1) CN1255425C (da)
AR (2) AR034561A1 (da)
AT (1) ATE403667T1 (da)
AU (3) AU9213201A (da)
BR (1) BR0114649A (da)
CA (1) CA2425572C (da)
CY (1) CY1108398T1 (da)
DE (1) DE60135240D1 (da)
DK (1) DK1328538T3 (da)
EG (1) EG23373A (da)
ES (2) ES2309094T3 (da)
GB (1) GB0025221D0 (da)
IL (2) IL155172A0 (da)
MX (1) MXPA03003302A (da)
MY (2) MY145819A (da)
NO (1) NO326020B1 (da)
NZ (1) NZ525096A (da)
PT (1) PT1328538E (da)
SA (1) SA01220570B1 (da)
SI (1) SI1328538T1 (da)
WO (1) WO2002032922A1 (da)
ZA (1) ZA200302526B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates
US7790910B2 (en) 2004-07-27 2010-09-07 Sicor Inc. Process for the preparation of 7α-alkylated 19-norsteroids
US20100174101A1 (en) * 2007-09-24 2010-07-08 Xi'an Liband Pharmaceutical Co., Ltd. Process for the manufacture of 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol
EP2070942A1 (de) * 2007-12-13 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Aromatisierung von 19-Nor-androst-4-en-3-onen zu Estra-1,3,5(10)-trienen
CN101525364B (zh) * 2008-03-07 2012-12-12 杭州九源基因工程有限公司 一种氟维司群的晶型及其制备方法
US8063249B1 (en) 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
CN102391341B (zh) * 2011-08-09 2013-05-22 福建省微生物研究所 制备6,7-脱氢-17β-烃酰氧基诺龙的方法
CN102600064A (zh) * 2012-03-31 2012-07-25 西安力邦制药有限公司 氟维司群或其衍生物缓释制剂及其制备方法
US9315540B2 (en) 2012-10-22 2016-04-19 Intas Pharmaceuticals Ltd. Process for the preparation of fulvestrant
CN103788164A (zh) * 2012-10-31 2014-05-14 正大天晴药业集团股份有限公司 一种氟维司群的制备方法
CN103965280B (zh) * 2014-05-21 2016-04-20 天津孚音生物科技发展有限公司 一种氟维司群中间体的制备方法
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
CN104387435B (zh) * 2014-12-10 2017-05-10 天津孚音生物科技发展有限公司 一种化合物及其制备方法与应用
KR101640747B1 (ko) 2015-05-20 2016-07-19 이금운 확장 가능형 끼움식 엘이디 조명 등기구
CN107488205A (zh) * 2016-06-13 2017-12-19 重庆圣华曦药业股份有限公司 一种氟维司群有关物质的制备方法及其在制剂中的检测方法
CN110818764A (zh) * 2018-08-07 2020-02-21 重庆圣华曦药业股份有限公司 一种应用加料监测系统制备氟维斯群中间体的方法
CN111018936B (zh) * 2019-11-12 2021-10-29 广州曼翔医药有限公司 一种氟维司群有关物质e的合成方法
CN116535454A (zh) * 2023-04-28 2023-08-04 香港中文大学（深圳） 氟维司群类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7305171A (da) * 1973-04-13 1974-10-15
GB8327256D0 (en) 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
DE4132182A1 (de) 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
US5211831A (en) * 1991-11-27 1993-05-18 Mcgean-Rohco, Inc. Process for extending the life of a displacement plating bath
DE19622457A1 (de) * 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
CA2402524C (en) * 2000-03-31 2009-11-17 Richard P. Blye Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) * 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates

Also Published As

Publication number Publication date
NO326020B1 (no) 2008-09-01
ES2581379T3 (es) 2016-09-05
IL155172A (en) 2012-04-30
EP1918295A2 (en) 2008-05-07
CY1108398T1 (el) 2014-02-12
IL155172A0 (en) 2003-10-31
EG23373A (en) 2005-02-28
AR034561A1 (es) 2004-03-03
AU2007201740B2 (en) 2010-04-08
SI1328538T1 (sl) 2008-12-31
JP2009215303A (ja) 2009-09-24
CN1479746A (zh) 2004-03-03
NO20031701D0 (no) 2003-04-11
AU2001292132B2 (en) 2007-01-25
NO20031701L (no) 2003-05-23
CA2425572C (en) 2010-03-09
JP5133937B2 (ja) 2013-01-30
AR082409A2 (es) 2012-12-05
JP2004511567A (ja) 2004-04-15
MY145819A (en) 2012-04-30
EP1918295B1 (en) 2016-04-06
DE60135240D1 (de) 2008-09-18
EP1328538A1 (en) 2003-07-23
AU9213201A (en) 2002-04-29
ATE403667T1 (de) 2008-08-15
MY149146A (en) 2013-07-15
KR100864266B1 (ko) 2008-10-20
US7947667B2 (en) 2011-05-24
EP1328538B1 (en) 2008-08-06
CN1255425C (zh) 2006-05-10
KR20030081319A (ko) 2003-10-17
EP1918295A3 (en) 2012-10-17
SA01220570B1 (ar) 2007-03-18
WO2002032922A1 (en) 2002-04-25
ZA200302526B (en) 2004-02-16
US20050101583A1 (en) 2005-05-12
AU2007201740A1 (en) 2007-05-10
KR20080056029A (ko) 2008-06-19
BR0114649A (pt) 2004-02-10
MXPA03003302A (es) 2003-08-07
PT1328538E (pt) 2008-09-30
ES2309094T3 (es) 2008-12-16
CA2425572A1 (en) 2002-04-25
JP4363846B2 (ja) 2009-11-11
GB0025221D0 (en) 2000-11-29
NZ525096A (en) 2004-10-29

Similar Documents

Publication Publication Date Title
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1334182T3 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1451143T3 (da) Fremgangsmåder til fremstilling af O-desmethylvenlafaxin
DK1323222T3 (da) Önet og fremgangsmåde til drift af et önet
DK1282719T3 (da) Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DK1309582T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
NO20021786D0 (no) Skumdempningsfremgangsmåter og sammensetninger
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1400522T3 (da) Forbindelser til behandling af impotens
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
DK1254159T3 (da) Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider